AACR Adaptive Biomarker-Driven Organ Preservation Trial in Gastroesophageal Adenocarcinomas
AACR Adaptive Biomarker-Driven Organ Preservation Trial in Gastroesophageal Adenocarcinomas
Recruiting · NCT07290985 · Registry updated 2026-10-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| AACR Adaptive Biomarker-Driven Organ Preservation Trial in Gastroesophageal Adenocarcinomas | gastroesophageal adenocarcinoma | Recruiting | Phase 2 | 2026-10-05 | NCT07290985 |
6 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| American Association for Cancer Research | 8 |
| Astellas Pharma Inc | 43 |
| BeOne Medicines | 76 |
| Jazz Pharmaceuticals | 60 |
| Natera, Inc. | 45 |
| Roche Diagnostics GmbH | 18 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| MD Anderson Cancer Center | Houston | United States | 589 |
| Princess Margaret Cancer Centre | Toronto | Canada | 22 |
| University of California, Los Angeles | Los Angeles | United States | 142 |
| Yale University | New Haven | United States | 352 |